Literature DB >> 20977873

Why do you need to move beyond first-line therapy for major depression?

Larry Culpepper1.   

Abstract

Primary care clinicians need to move beyond first-line therapy for major depression. While initial treatment is ineffective in about two-thirds of patients, patients who have not responded to such initial treatments can be managed effectively. The severity of depression is as high in primary care as in specialty care settings. The risk of depression is currently elevated because economic hardship, job insecurity, and low socioeconomic status increase the likelihood of depression and treatment resistance. Depression worsens outcomes for medical comorbidities, such as cardiac disease, chronic obstructive pulmonary disease, and diabetes mellitus, and it increases the risk of rehospitalization. When depression is treatment-resistant (generally defined as not responding to 2 courses of treatment of adequate dose and duration), morbidity and mortality are increased, quality of life and function are reduced, and long-term brain changes may occur. Opportunities for change in care are available. Screening for depression in primary care settings with staff-assisted support, adopting the concepts of the patient-centered medical home and stepped care, and using new treatment options such as atypical antipsychotics and other treatment modalities can improve outcomes for these patients. Now is the time to make these moves because new tools, systems, and treatments offer ways to help these patients. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977873     DOI: 10.4088/JCP.9104su1c.01

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  Strain differences in the effects of chronic corticosterone exposure in the hippocampus.

Authors:  G E Hodes; B R Brookshire; T E Hill-Smith; S L Teegarden; O Berton; I Lucki
Journal:  Neuroscience       Date:  2012-06-23       Impact factor: 3.590

Review 2.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

3.  Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors.

Authors:  Florian Seemüller; Sebastian Meier; Michael Obermeier; Richard Musil; Michael Bauer; Mazda Adli; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Michael Riedel; Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-03-04       Impact factor: 5.270

4.  Combined early life stressors: Prenatal nicotine and maternal deprivation interact to influence affective and drug seeking behavioral phenotypes in rats.

Authors:  Rosemary B Bassey; Marjorie C Gondré-Lewis
Journal:  Behav Brain Res       Date:  2018-07-25       Impact factor: 3.332

5.  Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net care.

Authors:  Kathleen Ell; Wayne Katon; Pey-Jiuan Lee; Suad Kapetanovic; Jeffrey Guterman; Bin Xie; Chih-Ping Chou
Journal:  Psychosomatics       Date:  2012-03-27       Impact factor: 2.386

6.  Differential induction of FosB isoforms throughout the brain by fluoxetine and chronic stress.

Authors:  Vincent Vialou; Mackenzie Thibault; Sophia Kaska; Sarah Cooper; Paula Gajewski; Andrew Eagle; Michelle Mazei-Robison; Eric J Nestler; A J Robison
Journal:  Neuropharmacology       Date:  2015-07-09       Impact factor: 5.250

Review 7.  The brain reward circuitry in mood disorders.

Authors:  Scott J Russo; Eric J Nestler
Journal:  Nat Rev Neurosci       Date:  2013-08-14       Impact factor: 34.870

8.  Treatment-resistant depression: therapeutic trends, challenges, and future directions.

Authors:  Khalid Saad Al-Harbi
Journal:  Patient Prefer Adherence       Date:  2012-05-01       Impact factor: 2.711

9.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

10.  Sex, stress, and epigenetics: regulation of behavior in animal models of mood disorders.

Authors:  Georgia E Hodes
Journal:  Biol Sex Differ       Date:  2013-01-21       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.